What CRO and Biopharma Partners say about working with Optimal

Articles

In It Together

We’re driven to deliver of high-quality data, with rapid enrolment, for greater study success and medical advancement. Discovery of greater solutions for people can only happen when you partner with passionate people – those who strive to innovate and create change.

This is why we work closely with local and global CROs and biopharma – including Pfizer, Novartis, Roche, Merck and a range of start-up biotechs – and support global programs with the FDA and EMA. Together we serve as a trusted hand to assist the journey of medicines to market.

“Optimal Clinical Trials exceeded recruitment targets and provided high-quality data in a very timely fashion. They were excellent to work with and we would definitely recommend them and look forward to working with them again in the future.”

– Global Pharmaceutical clinical project manager

“Optimal provided us with world class recruitment: 123% of the recruitment target in one third of the time allocated to the study.”

– Global CRO, director

“The team at Optimal Clinical Trials was instrumental in achieving our recruitment targets. Optimal came on as a rescue site and worked hard to enrol the most patients in New Zealand. They are a friendly, enthusiastic and committed team who respond quickly and go the extra mile to ensure outstanding patient recruitment and retention and quality data.”

– Australian CRO, senior CRA

How Our Customers Rate Us

Just like the pharmaceutical industry, we as a business continually aspire to improve and grow. Which is why we value the input from our customers – innovators, CROS, biotechs and pharmaceutical businesses and vendors – to ensure we deliver on results and expectations.

Here’s a snapshot of our most recent customer satisfaction survey and how our customers have scored us for the following key elements:

Key:

1 = Strongly disagree with the statement

5 = Strongly agree with the statement